DNA Repair Characteristics of Walker Rat Carcinoma Cells Sensitive and Resistant to Cis-Diamminedichloroplatinum(II) (Cisplatin) and Difunctional Alkylating Agents

  • J. J. Roberts
  • C. J. Rawlings
  • F. Friedlos
Part of the Developments in Oncology book series (DION, volume 23)


Studies on cultured cells have indicated the likely relevance of platinum DNA binding to cytotoxicity following their treatment with cis-diamminedichloroplatinum(II) (cisplatin) (1,2). DNA has been shown to be the only macromolecular target that is large enough to undergo more than one hit per molecule at pharmacologically relevant doses (1). Current evidence favours the view that damage to DNA leads to the inhibition of DNA synthesis and this in turn leads to cell death probably as a consequence of associated chromosomal damage. Cisplatin and di-functional alkylating agents can react with DNA to form both inter- and intra-strand crosslinks, crosslinks between DNA and protein and mono-functional adducts. A correlation between interstrand crosslinking and cytotoxicity has been demonstrated in the case of cis and trans diamminedichloroplatinum(II)-treated Hela (3) Chinese hamster (4) and mouse cells (5,6). Again, investigations in mouse leukaemia cells and normal and transformed human cells of varying sensitivity to cisplatin have shown that sensitivity often correlates well with interstrand crosslink formation (7,8,9). No similar correlation has been found for DNA-protein crosslinking and cytotoxicity in Chinese hamster (4) or mouse cells (6). In order to assess the possible importance of DNA crosslink formation we have studied the DNA excision repair characteristics of two lines of Walker rat cells sensitive and resistant to cisplatin and difunctional cytotoxic agents but not to monofunctional, cytotoxic agents. Additionally we have examined the biochemical responses of the two cell lines to DNA damage.


Sulphur Mustard Leukemia L1210 Cell Interstrand Crosslinking Murine Leukemia L1210 Cell L1210 Mouse Leukemia Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Roberts JJ, Thomson AJ: The mechanism of action of antitumor platinum compounds. Progr Nucl Acid Res Mol Biol (22): 71–133, 1979.CrossRefGoogle Scholar
  2. 2.
    Roberts JJ: Cisplatin in Cancer Chemotherapy. The EORTC Cancer Chemotherapy Annual 4. Pinedo HM (ed). Elsevier Medica Amsterdam, Oxford, 1982, pp. 95–117.Google Scholar
  3. 3.
    Pascoe JM, Roberts JJ: Interactions between mammalian cell DNA and inorganic platinum compounds. I DNA interstrand crosslinking and cytotoxic properties of platinum II compounds. Biochem Pharmacol (23): 1345–1357, 1974a.CrossRefGoogle Scholar
  4. 4.
    Zwelling LA, Bradley MO, Sharkey NA, Anderson T, Kohn KW: Cytotoxicity and DNA crosslinking in Chinese hamster cells treated with cis and trans Pt.II diammine dichloride. Mutation Res (67): 271–280, 1979.PubMedCrossRefGoogle Scholar
  5. 5.
    Zwelling LA, Kohn KW, Ross WE, Ewis RAG, Anderson T: Kinetics of formation and disappearance of a DNA crosslinking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloro platinum(II). Cancer Res (38): 1762–1768, 1978.PubMedGoogle Scholar
  6. 6.
    Zwelling LA, Anderson T, Kohn KW: DNA-protein and DNA interstrand crosslinking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells in relation to cytotoxicity. Cancer Res (39): 365–369, 1979a.Google Scholar
  7. 7.
    Zwelling LA, Michaels S, Schwartz H, Dobson PP and Kohn KW. DNA crosslinking as an indicator of sensitivity and resistance of mouse L1210 leukemia cells to cis-diamminedichloro platinum (II) and L- phenylalanine mustard. Cancer Res (41): 640–649, 1981.PubMedGoogle Scholar
  8. 8.
    Erickson LC, Zwelling LA, Ducore JM, Sharkey NA, Kohn KW: Differential cytotoxicity and DNA crosslinking in normal and transformed human fibroblasts treated with cis-diamminedichloroplatinum (II). Cancer Res (41): 2791–2794, 1981.PubMedGoogle Scholar
  9. 9.
    Laurent G, Erickson LC, Sharkey NA, Kohn KW: DNA crosslinking and cytotoxicity induced by cis diamminedichloroplatinum(II) on human normal and tumor cell lines. Cancer Res (41): 3347–3351, 1981.PubMedGoogle Scholar
  10. 10.
    Meyn RE, Jenkins SF, Thompson LH. Defective removal of DNA crosslinks in a repair-deficient mutant of Chinese hamster cells. Cancer Res (42): 3106–3110, 1982.PubMedGoogle Scholar
  11. 11.
    Ducore JM, Erickson LC, Zwelling LA, Laurent G, Kohn KW. Comparative studies of DNA crosslinking and cytotoxicity in Burketts lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L- phenylalanine mustard. Cancer Res (42): 897–902, 1982.PubMedGoogle Scholar
  12. 12.
    Strandberg MC, Bresnick E, Eastman A: The significance of DNA cross-linking to cis diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells. Chem Biol Interactions (39): 169–180, 1982.CrossRefGoogle Scholar
  13. 13.
    Shooter KV, House R, Merrifield RK, Robins AB: The interaction of platinum(II) compounds with bacteriophage T7 and R17. Chem Biol Interactions (5): 289–307, 1972.CrossRefGoogle Scholar
  14. 14.
    Filipski J, Kohn KW, Bonner WM: The nature of inactivating lesions produced by platinum(II) complexes in phage ϒ DNA. Chem Biol Interactions (32): 321–336, 1980.CrossRefGoogle Scholar
  15. 15.
    Tisdale MJ, Phillips BJ: Alterations in adenosine 3′, 5′-monophosphatebinding protein in Walker carcinoma cells sensitive or resistant to alkylating agents. Biochem Pharmacol (25): 1831–1836, 1976.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • J. J. Roberts
  • C. J. Rawlings
  • F. Friedlos

There are no affiliations available

Personalised recommendations